Squarepoint
CTSO icon

Squarepoint’s Cytosorbents Corp CTSO Stock Holding History

Squarepoint’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-586
Closed -$15K – 4461
2025
Q2 		$15K Sell
586
-1,441
-71% -$28.9K ﹤0.01% 4398
2025
Q1 		$40.5K Buy
+2,027
New +$42.7K ﹤0.01% 4374
2023
Q2 		– Sell
-568
Closed -$38.3K – 3633
2023
Q1 		$38.3K Buy
+568
New +$34.1K ﹤0.01% 3077
2022
Q1 		– Sell
-739
Closed -$62K – 2943
2021
Q4 		$62K Buy
+739
New +$82.9K ﹤0.01% 2999
2020
Q3 		– Sell
-4,241
Closed -$840K – 2537
2020
Q2 		$840K Buy
+4,241
New +$779K 0.01% 1041
2020
Q1 		– Sell
-1,002
Closed -$77K – 1982
2019
Q4 		$77K Buy
+1,002
New +$87.4K ﹤0.01% 2366

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Squarepoint's CTSO Position: Q3 2025 in Review

Squarepoint sold out of Cytosorbents Corp (CTSO) in Q3 2025, closing a stake of 586 shares — an estimated $15K sold.

Squarepoint first reported a position in CTSO in Q4 2019 and held it in 6 quarters. The position peaked at $840K in Q2 2020. 48 funds tracked by Wall St. Rank hold CTSO as of Q3 2025.

  • Squarepoint reported no remaining Cytosorbents Corp position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 586 Cytosorbents Corp shares in Q3 2025, an estimated $15K.
  • Squarepoint first reported a position in Cytosorbents Corp in Q4 2019 and held it in 6 quarters.
  • Squarepoint's Cytosorbents Corp position peaked at $840K in Q2 2020.
  • 48 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.